Product Information
AMLODIPINE-ATORVAST 5-20 MG is a generic product labeled by Apotex Corp., priced at $0.9219 per EA under NDC 60505348303. Its NADAC has been published 302 times since Sep 16, 2020.
Strength
5; 20 mg/1; mg/1
Manufacturer
Apotex Corp.NDC
60505348303
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205199On Market Since
7/29/2020
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-20 MG has been published 302 times since Sep 16, 2020, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9219 per EA |
|---|---|
| All-time high | $3.5336 (Nov 11, 2020) |
| All-time low | $0.5996 (May 21, 2025) |
| 52-week high | $1.0813 |
| 52-week low | $0.6001 |
| Median price | $1.7512 |
| Average price | $1.6639 |
| Largest weekly change | +57.2% (Sep 22, 2021) |
| Weeks tracked | 302 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-20 MG, manufactured by Apotex Corp., is $0.9219 per EA (NDC 60505348303), effective Jun 24, 2026.
How has the price of AMLODIPINE-ATORVAST 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-20 MG has declined 65.4%. It has been tracked across 302 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-20 MG?
Since Sep 16, 2020, the NADAC for AMLODIPINE-ATORVAST 5-20 MG has ranged from a low of $0.5996 (May 21, 2025) to a high of $3.5336 (Nov 11, 2020), with a median of $1.7512 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-20 MG?
2 NADAC-published products share the same active ingredient, strength, and dosage form as AMLODIPINE-ATORVAST 5-20 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 5-20 MG?
AMLODIPINE-ATORVAST 5-20 MG (NDC 60505348303) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification